199 related articles for article (PubMed ID: 34902522)
1. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma.
Li M; Jin S; Zhang Z; Ma H; Yang X
Cancer Lett; 2022 Feb; 527():28-40. PubMed ID: 34902522
[TBL] [Abstract][Full Text] [Related]
2. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract][Full Text] [Related]
3. Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis.
Savic D; Steinbichler TB; Ingruber J; Negro G; Aschenbrenner B; Riechelmann H; Ganswindt U; Skvortsov S; Dudás J; Skvortsova II
Cells; 2023 Jan; 12(2):. PubMed ID: 36672272
[TBL] [Abstract][Full Text] [Related]
4. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
5. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
6. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway.
Xu Q; Ma H; Chang H; Feng Z; Zhang C; Yang X
Cell Death Dis; 2020 May; 11(5):405. PubMed ID: 32471980
[TBL] [Abstract][Full Text] [Related]
7. Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).
Yang M; Guo R; Chen X; Song G; Zhang F
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37052257
[TBL] [Abstract][Full Text] [Related]
8. HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma.
Li J; Xiao W; Wei W; Wu M; Xiong K; Lyu J; Li Y
Mol Immunol; 2023 Jun; 158():79-90. PubMed ID: 37172353
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 promotes cancer progression via inhibiting ferroptosis in head and neck squamous cell carcinoma.
Lu T; Zhang Z; Pan X; Zhang J; Wang X; Wang M; Li H; Yan M; Chen W
J Oral Pathol Med; 2022 Jan; 51(1):52-62. PubMed ID: 34874578
[TBL] [Abstract][Full Text] [Related]
11. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
13. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
14. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
15. TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
Chen L; Lin W; Zhang H; Geng S; Le Z; Wan F; Huang Q; Chen H; Liu X; Lu JJ; Kong L
Cell Death Dis; 2024 Mar; 15(3):178. PubMed ID: 38429254
[TBL] [Abstract][Full Text] [Related]
16. Epithelial Membrane Protein 1 Promotes Sensitivity to RSL3-Induced Ferroptosis and Intensifies Gefitinib Resistance in Head and Neck Cancer.
Wang Y; Zhang L; Yao C; Ma Y; Liu Y
Oxid Med Cell Longev; 2022; 2022():4750671. PubMed ID: 35432717
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
18. Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Wang Z; Zong H; Liu W; Lin W; Sun A; Ding Z; Chen X; Wan X; Liu Y; Hu Z; Zhang H; Li H; Liu Y; Li D; Zhang S; Zha X
J Exp Clin Cancer Res; 2024 Apr; 43(1):112. PubMed ID: 38610018
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
20. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.
Song A; Wu L; Zhang BX; Yang QC; Liu YT; Li H; Mao L; Xiong D; Yu HJ; Sun ZJ
Cancer Lett; 2024 Apr; 588():216727. PubMed ID: 38431035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
